Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
Clinical trial NCT07152821 · TERMINATED
Trial details
- NCT number
- NCT07152821
- Sponsor
- Canadian Cancer Trials Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2026-07-13
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.